New progress in the orbital tumor treatment technology

Authors: Yu Jinhai,  Xu Qihua,  Liao Hongfei
DOI: 10.3760/cma.j.cn115989-20200924-00664
Published 2020-11-10
Cite as Chin J Exp Ophthalmol, 2020,38(11): 983-988.

Abstract

Orbital tumors not only damage the appearance of patients, but also damage the visual function, even endanger the life of patients.Orbital tumors can be divided into epidermal ectoderm, neuroectoderm, mesoderm, lymphopoietic system and metastatic tumors according to their origin.Due to the complex structure of orbital tissue, abundant nerve vessels and close connection with visual organs, it is more difficult and risky to treat orbital tumors than other regional tumors.Classic treatments for tumors include surgical resection, chemotherapy, and radiotherapy.Surgery is the main treatment for most orbital tumors.Due to the improvement of technology and equipment, it has been developed in the direction of minimally invasive surgery.For advanced tumors or lymphoid hematopoietic system tumors with extensive invasion, chemotherapy is the main treatment.Due to the improvement of drug delivery methods and protocols, it is developing towards high efficiency and less side effects.Radiotherapy is mostly used for refractory tumors that are difficult to be completely removed by surgery and easy to relapse.Due to the continuous improvement of radiotherapy technology, safe and accurate treatment has been achieved.In addition to the classical treatment methods, targeted treatment of carcinogenic sites at the molecular level has become a hot topic in the treatment of orbital tumors.This paper reviews the current development of orbital tumors in surgical resection, chemotherapy, radiotherapy and targeted therapy.

Key words:

Orbital tumors; Surgical resection; Chemotherapy; Radiotherapy

Contributor Information

Yu Jinhai
Key Laboratory of Ophthalmology of Jiangxi Province, Affiliated Eye Hospital of Nanchang University, Nanchang 330006, China
Xu Qihua
Department of Ocular Trauma, Affiliated Eye Hospital Of Nanchang University, Nanchang 330006, China
Liao Hongfei
Department of Ocular Trauma, Affiliated Eye Hospital Of Nanchang University, Nanchang 330006, China
(Read 14 times, 1 visits today)
Updated: November 19, 2020 — 3:14 am